Klaas Nico Faber

7PUBLICATIONS
29CO-AUTHORS
Innate immunityMolecular targetsLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 19, 2025
Butyrate suppresses mucosal inflammation in inflammatory bowel disease primarily through HDAC3 inhibition in monocytes and macrophages.

Daniela Parada-Venegas, Marjorie De la Fuente López, Karen Dubois-Camacho

|Apr 13, 2023
Letter: disentangling the role of redox-active compounds in the development of inflammatory bowel diseases - moving towards causal associations.

Sem Geertsema, Harry van Goor, Gerard Dijkstra

|Mar 27, 2023
Liver organoids: established tools for disease modeling and drug development.

Xi-Cheng Sun, De-Fu Kong, Jie Zhao

|Jun 15, 2022
Pro-Oxidant and Cytotoxic Effects of Tucum-Do-Cerrado (Bactris setosa Mart.) Extracts in Colorectal Adenocarcinoma Caco-2 Cells.

Renata Cristina da Silva, Raphael Rosa Fagundes, Klaas Nico Faber

|Jun 06, 2022
Serological biomarkers of type I, III and IV collagen turnover are associated with the presence and future progression of stricturing and penetrating Crohn's disease.

Arno R Bourgonje, Marta S Alexdottir, Antonius T Otten

|Nov 18, 2021
Inulin-grown Faecalibacterium prausnitzii cross-feeds fructose to the human intestinal epithelium.

Raphael R Fagundes, Arno R Bourgonje, Ali Saeed

Pageof 2

Frequent Collaborators

3 joint publications

Arno R Bourgonje

2 joint publications

Raphael Rosa Fagundes

2 joint publications

Rinse K Weersma

2 joint publications

Gerard Dijkstra